Abstract | GOAL: MATERIALS AND METHODS: FINDINGS: The multivariate adjusted hazard ratios (95% confidence intervals) of primary outcome, recurrent stroke, and vascular events were 1.54 (1.07-2.20), 1.78 (1.08-2.95), and 1.92 (1.26-2.94), respectively, in patients with both high galectin-3 and low HDL-C compared to those with both low galectin-3 and high HDL-C. The addition of galectin-3 and HDL-C to conventional factors significantly improved predictive value. Net reclassification index was 15.7% for primary outcome, 18.3% for recurrent stroke, and 20.5% for vascular events. CONCLUSION: Combination of high galectin-3 and low HDL-C was associated with primary outcome, recurrent stroke, and vascular events within 1 year after ischemic stroke, suggesting that the combination of galectin-3 and HDL-C may be used to identify the individuals at risk of poor prognosis after ischemic stroke.
|
Authors | Nimei Zeng, Aili Wang, Tan Xu, Chongke Zhong, Xiaowei Zheng, Zhengbao Zhu, Yanbo Peng, Hao Peng, Qunwei Li, Zhong Ju, Deqin Geng, Yonghong Zhang, Jiang He |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 28
Issue 7
Pg. 1879-1885
(Jul 2019)
ISSN: 1532-8511 [Electronic] United States |
PMID | 31085131
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Blood Proteins
- Cholesterol, HDL
- Galectin 3
- Galectins
- LGALS3 protein, human
|
Topics |
- Adult
- Aged
- Biomarkers
(blood)
- Blood Proteins
- Brain Ischemia
(blood, diagnosis, mortality, therapy)
- China
- Cholesterol, HDL
(blood)
- Female
- Galectin 3
(blood)
- Galectins
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- Recurrence
- Risk Assessment
- Risk Factors
- Single-Blind Method
- Stroke
(blood, diagnosis)
- Time Factors
- Young Adult
|